SCIENTIFIC PROGRAM 9th Mar 2018 PLENARY SESSION TIME Topic Speaker CHAIRPERSON 8.30-9.00hrs [Death determined by neurological criteria: the nex steps Prof Citerio 0.00.9.20hrs [inning the war against ICU-acquired weakness: new innovations iN | pau wigchmeyer nutrition and exercise physiology 9.30-1000hs [10 Barriers of EOL in INDIA Dr Divaiia J [Evolution of Technology for Continuous Renal Replacement Therapy. 10.00-10.30h's [Forty Years of Improvernenis. Dr. Rajesh Chekravarti [Scrub typhus: when to suspect and how to manage? IHALLNO 4 TROPICAL ILLNESS THEMATIC SESSIONS 1 TIME Topic Speaker CHAIRPERSON 10.20.10.46nrs _[Hemophagocytic syndrome in tropical infection: whento Suspect ANG [oy Hy Choudhary lhow to manage 70.45-11.00h'S _| Pltelet transfusion in Dengue: current Strategy. Dr Narendra Rungta 44.00-11.15hrs | Leptospirosis:when to suspect and how to manage? ee ouna: 711511200 [DISCUSSION 17.30-11.45h's [Scrub typhus. when fo suspect and how to manage? Drkhalic 77.45-12.00hrs [Management of severe dengue: are WHO guidelines relevant? [Dr Gopainath 12.00-12.15hrs | Management of severe malaria. are WHO guidelines relevant? |Dr Madhuker Rai 12.15-12.30hrs DISCUSSION QA 12.30-1.30 HRS LUNCH BREAK [Decontaminating surfaces and medical equipment: what's new and 4.30-4.45hrs Dr Ramen Sardana practical? 745-2.00hrs ls pseucomonas vaccine in ventilated ICU patients the future? Dr Tobias Wette 2.00-2.48hrs Isolation or cohoarting - which is practicel? DrJV Peter 245-220hrs _ |DISCUSSIONIQIA’ | TEAICOFFEE SERVED ALL THROUGH AFTERNOON 2.20-2.46hrs [Immune Encephalitis : Role of intensivist Dr Rajesh mishra 245-300 [Septic encephalopathy Dr Narendra Rungta 300-3.48hrs [Un ver in OU, Approach Dr Pradip Dcosta 315.330nrs _|DISCUSSIONGIA HALL NO 2 RESPIRATORY MONITORING. [ THEMATIC SESSIONS 5 TIME Topic Speaker CHAIRPERSON 10.30-10.45hrs [Airways management duting CPR Dr Manish Munjal 10.45-17.00hrs Inability to clear secretion: how to manage. Dr Ranveer Tyagi 11.00-17.15hrs |Weaning'speaking/swallowing on tracheostomy. Dr Diptimala Agarwal 14.15-17.30hs DISCUSSION QiA 11.30-17.45hrs [ARDS mimics in ICU Dr Brian K 41.45-12.00hrs Berlin definition of ARDS: does it need to be modified’? Dr.Massimo Antonelli 412.00-12.15hrs PEEP titration: current status Dr.Chitra Mehta 12.15-12.30hrs DISCUSSION QA 12.30-1.30 HRS. LUNCH BREAK 130-1.45tvs__|HOV in paediatric ARDS-current status Dr Anil Sachdev 145-2.00hrs _|Fluids, steroids and Neuro muscular blockage in ARDS pis. Dr Atul Kulkarni 2.00-2 15s __| Rescue therapy in ARDS (prone and ECMO) - Dr Sandeep Deewan 2.15-230ns _|DISCUSSIONIGIAT [ TEAICOFFEE SERVED ALL THROUGH AFTERNOON 2.30-2.45nrs __[ARDS: Functional Resudual capacity Prof.Chich 2.45.3.00nrs _|Hyperoxia in ICU: implications Dr Banamber Ra 3.00-3.15hrs__|Use of high fiow oxyaen in hypercapneic respiratory failure Dr Brian K 3.15.330nrs [DISCUSSION GIAI [ HALLNO 3 GENERAL CRITICAL CARE | [THEMATIC SESSIONS 09 | TIME Topic Speaker CHAIRPERSON 70:30-10-45hrs [Non pharmacological prophylaxis of VTE: Role in ICU Dr. Saurabh Sahagal 10.45-11.00hrs | Newer anticoagulants Dr Gaurav Jain 17.00-11.16hrs | NON thrombotic Pulmonary embolism (FAT/ARVANNIOTIC) Dr Mohan Maharaj 1115-1130hs [DISCUSSION | 171.20-12.15PM DEBATE Dr Yatin mehta (con) Extracorporeal theraphy in sepsis: still place in ICU ieeeees) 42.45-12.30hs DISCUSSION GIA 12,30-1.30 HRS. LUNCH BREAK 1.30-1.46hrs [High risk pregnancy. role of intensivist DR Sunil Pandya 1.45-2.00hrs Management of obstetric haemorrhage: Recent advances Dr Bande 8 2.00-2.15hrs, Managing seizers in ICU. Dr Harsh Sapra 2.45-2.30hrs DISCUSSION QA I TEAICOFFEE SERVED ALL THROUGH AFTERNOON. 2:30-2.45hrs [When to measure & how to interprete blood lactatein icu? Dr. Sheil Bhosale 2.45-3.00hrs: Measuring Sc Vo2: is it relevent today? Dr.Sameer Jog 3.00-3.15hrs [Endothelial dysfuntion, Assement & management Dr. Jose Chacko 3152.20hrs _ |DISCUSSIONIGIAT [ HALLNO4 SEPSIS [THEMATIC SESSIONS 13 SEPSIS TIME Topic Speaker CHAIRPERSON Dr. Arunaloke 10.30-10.45hrs [Emerging Fungal Infections ciosard 70.45-11.00hrs _|Candidemia in ICU: New guidelines. Dr Arvind Barna 17.00-11.15hrs [Management of mucormycosis Dr. Babu Abraham 11.15-11.30hrs [DISCUSSIONIGAT 41.30-11.45hrs [Biomarkers for fungal infection: current status DR Divatia Dr-Suresh 41.45-42.00hrs | PkiPd of antifungal drugs. Haseley 12.00-12.Tehrs [antifungal stewardship. Dr. Subhash. Todi 12.15-12.30hrs DISCUSSION GIA 12,30-1.30 HRS. LUNCH BREAK Uillty of surveillance bacterial culture in ICU in choosing empiric 1.20-1.45hrs —_|antiiote Dr Sanjay Bhattacharya 745-2.00hrS [PCR based diagnostics tocs, are they rea for prime time? Br Farhad Kapadia 2.00-2.15hrs Experience with Maldi TOFIPCR Pr eee e f Chakrabart 2.152.00h [DISCUSSION I TEAICOFFEE SERVED ALL THROUGH AFTERNOON 2.30-2.48hrs [Sepsis quidelnes: how to improve complance. Dr Supradeeo Ghosh 2.45-3.00hrs | PRESPSIN - a new biomarker Br Quirinapiacevol 3.00-3.15hrs_| New surviving the guidelines: What has changed? Dr Mohd Omar Farook 3.15320 [DISCUSSION HALLNOS GENERAL | MHEMATIC SESSIONS 17 GENERAL TIME Topic Speaker CHAIRPERSON 10.30-10.45hrs [Care of bone marrow transplant patient Role of intensivist Dr Abhinav Gupta 10.45-17.00hrs DCD (donation afier cardiac death)-current status. Dr-Rajhance Prasad 14.00-17.15hrs Management of the potential Organ Donor in the PICU Dr Bala Ramachandran 11.15-17.30hrs DISCUSSION QA 11.30-17.45hrs Ketamine /Dexmetadinbenzo/fentanyl: Anage sedation in ICU: Dr Pradeep Bhattacharya 11.45-12.00hrs [Therapeutic Drug Monitoring in ICU Dr Rajesh Pande 412.00-12.15hrs ICU Pharmacist: Utility Dr Sumit Ray 12.15-12.30hrs DISCUSSION QA 12.30-1.30 HRS. LUNCH BREAK 130-1.45hrs [Use of technology in ICU Nutition Dr Sanjt Sridharan 145-2.00hs [Feeding enterally hemodynamicaly unstable patient is it feasible’ Dr Subhal Dixit 2.00-2 15s __|Individualising ICU nutrition. Dr Pravin Amin 2.152.30ns _ |DISCUSSIONOIAT TEAICOFFEE SERVED ALL THROUGH AFTERNOON 2.30-2.45hrs Achieving Glucose control Dr Rajesh Baraoker 2.45.3.00nrs _ |Hypoglycaemia in ICU: Detection, prevention and management [Dr Shrinivas Samavedan 3.00-3.15hrs __|Individualizing glucose control in ICU. DRA SM Areef Ahsan 3.15.3.30ns [DISCUSSION GIA’ I